CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART

Abstract

The two strategies may be considered clinically equivalent. CD4 cell-guided STIs seem a possible alternative for chronically infected individuals responding to HAART provided that CD4 cell decrements would be steadily maintained above a safe threshold.